Wenling Han
hanwl@bjmu.edu.cn
Chinese, English
Beijing
Peking University
Basic Medical Sciences
  • 1989-1994: Bachelor of Medicine, Taishan Medical University
  • 1994-1999: PhD in Medicine, Beijing Medical University, Supervisor: Professor Ma Dalong
  • First to report the new gene family CMTM internationally
  • Published 44 SCI papers as first author or corresponding author
  • 1999-2001: Lecturer, Peking University Medical Department
  • 2001-2006: Associate Professor, Peking University Medical Department
  • 2006-Present: Professor, Peking University Medical Department
  • 2002: National Excellent Doctoral Dissertation Award and First Prize of Peking University Excellent Doctoral Dissertation
  • 2002: Outstanding Young Teacher of Peking University Medical Department
  • 2003: Best Oral Presentation Award at the 1st International Conference on Cytokines and Medicine
  • 2004: Huo Yingdong Young Teacher Award
  • 2004: Second Prize of Natural Science from the Ministry of Education as the first finisher
  • 2005: Young Talent of Peking University Medical Department and Beijing City
  • 2007: Cross-Century Excellent Talent by the Ministry of Education
  • 2007: Fourth China Young Women Scientist Nomination Award
  • 2008: Beijing March 8th Red-Banner Pacesetter
  • 2008: Young Scholar of Peking University Medical Department
  • 2010: Good Teacher and Helpful Friend of Peking University Medical Department
  • 2013: Excellent SCI Paper Award of Peking University Basic Medical College
  • 2015: Peking University Excellent Doctoral Dissertation Supervisor Award
  • 2017: Peking University Excellent Doctoral Dissertation Supervisor Award
  • 2021: Star of the Tenth Female Faculty of Peking University Medical Department
  • 2021: Peking University Zhongwai Medical Award
Function, mechanism, and application research of new cytokines and immune membrane molecules
  • Molecular cloning and characterization of chemokine-like factor 1 (CKLF1), a novel human cytokine with unique structure and potential chemotactic activity, Han W, Lou Y, Tang J, Zhang Y, Chen Y, Li Y, Gu W, Huang J, Gui L, Tang Y, Li F, Song Q, Di C, Wang L, Shi Q, Sun R, Xia D, Rui M, Tang J, Ma D, 2001
  • Identification of eight genes encoding chemokine-like factor superfamily members 1-8 (CKLFSF1-8) by in silico cloning and experimental validation, Han W, Ding P, Xu M, Wang L, Rui M, Shi S, Liu Y, Zheng Y, Chen Y, Yang T, Ma D, 2003
  • Molecular cloning and identification of mouse Cklfsf2a and Cklfsf2b, two homologues of human CKLFSF2, Li T, Han W, Yang T, Ding P, Rui M, Liu D, Wang Y, Ma D, 2006
  • Expression of chemokine-like factor 1 is upregulated during T lymphocyte activation, Li T, Zhong J, Chen Y, Qiu X, Zhang T, Ma D, Han W, 2006
  • Characterization and expression profile of CMTM3/CKLFSF3, Zhong J, Wang Y, Qiu X, Mo X, Liu Y, Li T, Song Q, Ma D, Han W, 2006
  • CMTM3 can affect the transcription activity of androgen receptor and inhibit the expression level of PSA in LNCaP cells, Wang Y, Li T, Qiu X, Mo X, Zhang Y, Song Q, Ma D, Han W, 2008
  • PTPIP51, a novel 14-3-3 binding protein, regulates cell morphology and motility via Raf-ERK pathway, Yu C, Han W, Shi T, Lv B, He Q, Zhang Y, Li T, Zhang Y, Song Q, Wang L, Ma D, 2008
  • CMTM5-v1 induces apoptosis in cervical carcinoma cells, Shao L, Guo X, Plate M, Li T, Wang Y, Ma D, Han W, 2009
  • CMTM5 induces apoptosis of pancreatic cancer cells and has synergistic effects with TNF-alpha, Guo X, Li T, Wang Y, Shao L, Zhang Y, Ma D, Han W, 2009
  • Expressional and functional studies of CKLF1 during dendritic cell maturation, Shao L, Li T, Mo X, Majdic O, Zhang Y, Seyerl M, Schrauf C, Ma D, Stöckl J, Han W, 2010
  • Identification and characterization of CMTM4, a novel gene with inhibitory effects on HeLa cell growth through inducing G2/M phase accumulation, Plate M, Li T, Wang Y, Mo X, Zhang Y, Ma D, Han W, 2010
  • CMTM5-v1, a four-transmembrane protein, presents a secreted form released via a vesicle-mediated secretory pathway, Li H, Guo X, Shao L, Plate M, Mo X, Wang Y, Han W, 2010
  • VSTM1-v2, a novel soluble glycoprotein, promotes the differentiation and activation of Th17 cells, Guo X, Zhang Y, Wang P, Li T, Fu W, Mo X, Shi T, Zhang Z, Chen Y, Ma D, Han W, 2012
  • Preparation and characterization of monoclonal antibodies against VSTM1, Li T, Wang W, Chen Y, Han W, 2013
  • A role for CMTM7 in BCR expression and survival in B-1a but not B-2 cells, Zhang Y, Wang JY, Han W, 2014
  • CARD9 mutations linked to subcutaneous phaeohyphomycosis and TH17 cell deficiencies, Wang X, Wang W, Lin Z, Wang X, Li T, Yu J, Liu W, Tong Z, Xu Y, Zhang J, Guan L, Dai L, Yang Y, Han W, Li R, 2014
  • A novel 3p22.3 gene CMTM7 represses oncogenic EGFR signaling and inhibits cancer cell growth, Li H, Guo X, Shao L, Plate M, Mo X, Wang Y, Han W, 2014
  • CSBF/C10orf99, a novel potential cytokine, inhibits colon cancer cell growth through inducing G1 arrest, Pan W, Cheng Y, Zhang H, Liu B, Mo X, Li T, Li L, Cheng X, Zhang L, Ji J, Wang P, Han W, 2014
  • FAM19A4 is a novel cytokine ligand of formyl peptide receptor 1 (FPR1) and is able to promote the migration and phagocytosis of macrophages, Wang W, Li T, Wang X, Yuan W, Cheng Y, Zhang H, Xu E, Zhang Y, Shi S, Ma D, Han W, 2015
  • V-set and transmembrane domain containing 1 is silenced in human hematopoietic malignancy cell lines with promoter methylation and has inhibitory effects on cell growth, Li T, Guo X, Wang W, Mo X, Wang P, Han W, 2015
  • CARD9 deficiencies linked to impaired neutrophil functions against Phialophora verrucosa, Liang P, Wang X, Wang R, Wan Z, Han W, Li R, 2015
  • The Secreted Form of Transmembrane Protein 98 Promotes the Differentiation of T Helper 1 Cells, Fu W, Cheng Y, Zhang Y, Mo X, Li T, Liu Y, Wang P, Pan W, Chen Y, Xue Y, Ma D, Zhang Y, Han W, 2015
  • Eff
Cytokines Immune Membrane Molecules Cell Interactions Physiological Functions Drug Development Tumor Microenvironment Autoimmune Diseases Clinical Translation Immune Checkpoints Targeted Therapy

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.